MANNKIND CORP (30) | Supply Agreements (7)
Recent Contracts
-
Second Amendment to Commercial Supply Agreement, dated June 15, 2022, by and between MannKind Corporation and United Therapeutics Corporation
(Filed With SEC on February 23, 2023)
-
Third Amendment to Commercial Supply Agreement, dated August 31, 2022, by and between MannKind Corporation and United Therapeutics Corporation
(Filed With SEC on February 23, 2023)
-
Fourth Amendment to Commercial Supply Agreement, dated December 22, 2022, by and between MannKind Corporation and United Therapeutics Corporation
(Filed With SEC on February 23, 2023)
-
Commercial Supply Agreement, dated August 12, 2021, by and between MannKind Corporation and United Therapeutics Corporation
(Filed With SEC on November 9, 2021)
-
First Amendment to Commercial Supply Agreement, dated October 16, 2021, by and between MannKind Corporation and United Therapeutics Corporation
(Filed With SEC on November 9, 2021)
-
Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S
(Filed With SEC on February 25, 2021)
-
Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc
(Filed With SEC on February 26, 2019)
